{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:45:28Z","timestamp":1784771128485,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13014-016-0732-5","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T20:36:49Z","timestamp":1480711009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["SBRT for centrally localized NSCLC \u2013 What is too central?"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8863-9524","authenticated-orcid":false,"given":"J.","family":"Roesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Panje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sterzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,3]]},"reference":[{"key":"732_CR1","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374\u2013403. doi: 10.1016\/j.ejca.2012.12.027 .","journal-title":"Eur J Cancer"},{"key":"732_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390. doi: 10.3322\/caac.20107 .","journal-title":"CA Cancer J Clin"},{"key":"732_CR3","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Lung Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012 n.d."},{"key":"732_CR4","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","volume":"27","author":"BD Smith","year":"2009","unstructured":"Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27:2758\u201365. doi: 10.1200\/JCO.2008.20.8983 .","journal-title":"J Clin Oncol"},{"key":"732_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395\u2013409. doi: 10.1056\/NEJMoa1102873 .","journal-title":"N Engl J Med"},{"key":"732_CR6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1034\/j.1399-3003.1999.14b29.x","volume":"14","author":"M Perrot de","year":"1999","unstructured":"de Perrot M, Licker M, Reymond MA, Robert J, Spiliopoulos A. Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma. Eur Respir J. 1999;14:419\u201322.","journal-title":"Eur Respir J"},{"key":"732_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630\u20137. doi: 10.1016\/S1470-2045(15)70168-3 .","journal-title":"Lancet Oncol"},{"key":"732_CR8","doi-asserted-by":"publisher","unstructured":"Dahele M, Hatton M, Slotman B, Guckenberger M. Stereotactic body radiotherapy: A survey of contemporary practice in six selected European countries. Acta Oncol Stockh Swed 2015:1\u20135. doi: 10.3109\/0284186X.2014.1003961","DOI":"10.3109\/0284186X.2014.1003961"},{"key":"732_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/JTO.0b013e318279155f","volume":"8","author":"ME Daly","year":"2013","unstructured":"Daly ME, Perks JR, Chen AM. Patterns-of-care for thoracic stereotactic body radiotherapy among practicing radiation oncologists in the United States. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2013;8:202\u20137. doi: 10.1097\/JTO.0b013e318279155f .","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"732_CR10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/S0003-4975(01)02406-7","volume":"71","author":"MP Siegenthaler","year":"2001","unstructured":"Siegenthaler MP, Pisters KM, Merriman KW, Roth JA, Swisher SG, Walsh GL, et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg. 2001;71:1105\u201312. doi: 10.1016\/S0003-4975(01)02406-7 .","journal-title":"Ann Thorac Surg"},{"key":"732_CR11","first-page":"413","volume":"50","author":"M Saito","year":"2002","unstructured":"Saito M, Furukawa K, Miura T, Kato H. Evaluation of T factor, surgical method, and prognostic factors in central type lung cancer. Jpn J Thorac Cardiovasc Surg Off Publ Jpn Assoc Thorac Surg Nihon Ky\u014dbu Geka Gakkai Zasshi. 2002;50:413\u20137.","journal-title":"Jpn J Thorac Cardiovasc Surg Off Publ Jpn Assoc Thorac Surg Nihon Ky\u014dbu Geka Gakkai Zasshi"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","volume":"24","author":"R Timmerman","year":"2006","unstructured":"Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24:4833\u20139. doi: 10.1200\/JCO.2006.07.5937 .","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"732_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2013.07.022","volume":"109","author":"U Nestle","year":"2013","unstructured":"Nestle U, Faivre-Finn C, DeRuysscher D, Hurkmans C, Guckenberger M, Belderbos J, et al. Stereotactic body radiotherapy (SBRT) in central non-small cell lung cancer (NSCLC): solid evidence or \u201cno-go\u201d? Radiother Oncol J Eur Soc Ther Radiol Oncol. 2013;109:178\u20139. doi: 10.1016\/j.radonc.2013.07.022 .","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"732_CR14","doi-asserted-by":"publisher","first-page":"20150036","DOI":"10.1259\/bjr.20150036","volume":"88","author":"S Adebahr","year":"2015","unstructured":"Adebahr S, Collette S, Shash E, Lambrecht M, Le Pechoux C, Faivre-Finn C, et al. LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective. Br J Radiol. 2015;88:20150036. doi: 10.1259\/bjr.20150036 .","journal-title":"Br J Radiol"},{"key":"732_CR15","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.07.033","volume":"75","author":"RD Timmerman","year":"2009","unstructured":"Timmerman RD, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients: analysis of RTOG 0236. Int J Radiat Oncol. 2009;75:S3. doi: 10.1016\/j.ijrobp.2009.07.033 .","journal-title":"Int J Radiat Oncol"},{"key":"732_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA J Am Med Assoc. 2010;303:1070\u20136. doi: 10.1001\/jama.2010.261 .","journal-title":"JAMA J Am Med Assoc"},{"key":"732_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/JTO.0000000000000453","volume":"10","author":"JY Chang","year":"2015","unstructured":"Chang JY, Bezjak A, Mornex F, Advanced Radiation Technology Committee IASLC. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10:577\u201385. doi: 10.1097\/JTO.0000000000000453 .","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"732_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijrobp.2015.10.040","volume":"94","author":"A Bezjak","year":"2016","unstructured":"Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, et al. Primary study endpoint analysis for NRG oncology\/RTOG 0813 trial of Stereotactic Body Radiation Therapy (SBRT) for centrally located Non-Small Cell Lung Cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2016;94:5\u20136. doi: 10.1016\/j.ijrobp.2015.10.040 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"732_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.radonc.2011.12.023","volume":"102","author":"JJ Nuyttens","year":"2012","unstructured":"Nuyttens JJ, van der Voort van Zyp NC, Praag J, Aluwini S, van Klaveren RJ, Verhoef C, et al. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2012;102:383\u20137. doi: 10.1016\/j.radonc.2011.12.023 .","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"732_CR20","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1097\/JTO.0b013e31822e71d8","volume":"6","author":"CJA Haasbeek","year":"2011","unstructured":"Haasbeek CJA, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2011;6:2036\u201343. doi: 10.1097\/JTO.0b013e31822e71d8 .","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"732_CR21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lungcan.2015.04.014","volume":"89","author":"AA Chaudhuri","year":"2015","unstructured":"Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, et al. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer Amst Neth. 2015;89:50\u20136. doi: 10.1016\/j.lungcan.2015.04.014 .","journal-title":"Lung Cancer Amst Neth"},{"key":"732_CR22","doi-asserted-by":"publisher","unstructured":"Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, et al. Outcomes of hypo-fractionated high dose radiotherapy in poor risk patients with \u201cultra-central\u201d non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2016. doi: 10.1016\/j.jtho.2016.03.008","DOI":"10.1016\/j.jtho.2016.03.008"},{"key":"732_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.radonc.2015.09.028","volume":"117","author":"H Tekatli","year":"2015","unstructured":"Tekatli H, Senan S, Dahele M, Slotman BJ, Verbakel WFAR. Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2015;117:64\u201370. doi: 10.1016\/j.radonc.2015.09.028 .","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"732_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijrobp.2007.10.053","volume":"70","author":"FJ Lagerwaard","year":"2008","unstructured":"Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685\u201392. doi: 10.1016\/j.ijrobp.2007.10.053 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"732_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2008.06.1939","volume":"74","author":"M Guckenberger","year":"2009","unstructured":"Guckenberger M, Wulf J, Mueller G, Krieger T, Baier K, Gabor M, et al. Dose\u2013response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys. 2009;74:47\u201354. doi: 10.1016\/j.ijrobp.2008.06.1939 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"732_CR26","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.ijrobp.2010.12.039","volume":"82","author":"M Taremi","year":"2012","unstructured":"Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, et al. Stereotactic Body Radiotherapy for Medically Inoperable Lung Cancer: Prospective, Single-Center Study of 108 Consecutive Patients. Int J Radiat Oncol. 2012;82:967\u201373. doi: 10.1016\/j.ijrobp.2010.12.039 .","journal-title":"Int J Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-016-0732-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T01:11:01Z","timestamp":1498353061000},"score":1,"resource":{"primary":{"URL":"http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-016-0732-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1186\/s13014-016-0732-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"157"}}